カテゴリ： GlobalData, アメリカ, 企業調査

Exosome Diagnostics Inc：企業の製品パイプライン分析2018

◆英語タイトル：Exosome Diagnostics Inc - Product Pipeline Analysis, 2018 Update
◆商品コード：DATA904C2778
◆発行会社（調査会社）：GlobalData
◆発行日：2018年8月
◆ページ数：41
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD1,500 ⇒換算￥222,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD2,250 ⇒換算￥333,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
Exosome Diagnostics Inc (Exosome Diagnostics) is a provider of diagnostic solutions. The company develops, designs, manufactures and markets biofluid-based molecular diagnostic tests and products for use in personalized medicine. Exosome Diagnostics’ services comprise miRNA profiling, mRNA profiling, mutation detection, ribonucleic acid (RNA) sequencing (including full RNA seq) and custom assay development services. The company also offers disease detection, diagnosis, treatment and monitoring. Its technology is used in the treatment of brain cancer, prostate cancer, and Alzheimer’s disease. Exosome Diagnostics is headquartered in Waltham, Massachusetts the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Exosome Diagnostics Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Exosome Diagnostics Inc Company Overview 5
Exosome Diagnostics Inc Company Snapshot 5
Exosome Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview 5
Exosome Diagnostics Inc – Pipeline Analysis Overview 7
Exosome Diagnostics Inc – Key Facts 7
Exosome Diagnostics Inc – Major Products and Services 8
Exosome Diagnostics Inc Pipeline Products by Development Stage 9
Exosome Diagnostics Inc Ongoing Clinical Trials by Trial Status 11
Exosome Diagnostics Inc Pipeline Products Overview 13
Biofluid Nucleic Acid Kit – Alzheimer’s Disease 13
Biofluid Nucleic Acid Kit – Alzheimer’s Disease Product Overview 13
Biofluid Nucleic Acid Kit – Cardiovascular Disease 14
Biofluid Nucleic Acid Kit – Cardiovascular Disease Product Overview 14
Biofluid Nucleic Acid Kit – Chronic Kidney Disease 15
Biofluid Nucleic Acid Kit – Chronic Kidney Disease Product Overview 15
Biofluid Nucleic Acid Kit – Parkinson’s Disease 16
Biofluid Nucleic Acid Kit – Parkinson’s Disease Product Overview 16
Biofluid-Based Molecular Diagnostic Test – Brain Cancer 17
Biofluid-Based Molecular Diagnostic Test – Brain Cancer Product Overview 17
BIONIC Liquid Biopsy – Bladder Cancer 18
BIONIC Liquid Biopsy – Bladder Cancer Product Overview 18
Diagnostic Test – Neurodegenerative Diseases 19
Diagnostic Test – Neurodegenerative Diseases Product Overview 19
EXO1000 20
EXO1000 Product Overview 20
ExoDx Lung(EGFR) 21
ExoDx Lung(EGFR) Product Overview 21
ExoDx Lung(EGFR) Clinical Trial 22
ExoDx Lung(T790M) 23
ExoDx Lung(T790M) Product Overview 23
ExoDx Prostate(IntelliScore) – IVD Version 24
ExoDx Prostate(IntelliScore) – IVD Version Product Overview 24
ExoDx Prostate(IntelliScore) – IVD Version Clinical Trial 25
Next-Generation Solid Tumor Mutation Panel 26
Next-Generation Solid Tumor Mutation Panel Product Overview 26
Shahky 27
Shahky Product Overview 27
Exosome Diagnostics Inc – Key Competitors 28
Exosome Diagnostics Inc – Key Employees 29
Exosome Diagnostics Inc – Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Recent Developments 31
Exosome Diagnostics Inc, Recent Developments 31
Jun 13, 2018: Exosome Diagnostics Receives ISO 13485:2016 Certification 31
May 22, 2018: Exosome Diagnostics Announces Bladder Cancer Surveillance Panel 31
May 17, 2018: Exosome Diagnostics’ Second Prospective Validation Study of EPI to be Highlighted at American Urological Association (AUA) Annual Meeting Press Briefing in San Francisco, CA 32
May 15, 2018: Exosome Diagnostics Presents Breakthrough Data Highlighting Tumor Derived RNA in Biofluids at the International Society for Extracellular Vesicles in Spain 33
May 09, 2018: Exosome Diagnostics Continues to Expand Coverage Reach for its EPI Test 33
May 08, 2018: Exosome Diagnostics Expands National Sales Team after Blockbuster Quarter with its Flagship Diagnostic, ExoDx Prostate(IntelliScore) (EPI) Test 34
Apr 17, 2018: Exosome Diagnostics Obviates Tissue Biopsies 34
Mar 21, 2018: Exosome Diagnostics Names Grannum Sant As Head Of Medical Affairs 35
Feb 23, 2018: Exosome Diagnostics Expands its Coverage Reach for EPI to an Additional 82 Million Covered Lives in the United States 36
Feb 23, 2018: NIH Launches International Study of AMD Progression 36
Appendix 38
Methodology 38
About GlobalData 41
Contact Us 41
Disclaimer 41

List of Tables
Exosome Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview 5
Exosome Diagnostics Inc Pipeline Products by Equipment Type 6
Exosome Diagnostics Inc Pipeline Products by Indication 6
Exosome Diagnostics Inc Ongoing Clinical Trials by Trial Status 6
Exosome Diagnostics Inc, Key Facts 7
Exosome Diagnostics Inc, Major Products and Services 8
Exosome Diagnostics Inc Number of Pipeline Products by Development Stage 9
Exosome Diagnostics Inc Pipeline Products Summary by Development Stage 10
Exosome Diagnostics Inc Ongoing Clinical Trials by Trial Status 11
Exosome Diagnostics Inc Ongoing Clinical Trials Summary 12
Biofluid Nucleic Acid Kit - Alzheimer's Disease - Product Status 13
Biofluid Nucleic Acid Kit - Alzheimer's Disease - Product Description 13
Biofluid Nucleic Acid Kit - Cardiovascular Disease - Product Status 14
Biofluid Nucleic Acid Kit - Cardiovascular Disease - Product Description 14
Biofluid Nucleic Acid Kit - Chronic Kidney Disease - Product Status 15
Biofluid Nucleic Acid Kit - Chronic Kidney Disease - Product Description 15
Biofluid Nucleic Acid Kit - Parkinson's Disease - Product Status 16
Biofluid Nucleic Acid Kit - Parkinson's Disease - Product Description 16
Biofluid-Based Molecular Diagnostic Test - Brain Cancer - Product Status 17
Biofluid-Based Molecular Diagnostic Test - Brain Cancer - Product Description 17
BIONIC Liquid Biopsy - Bladder Cancer - Product Status 18
BIONIC Liquid Biopsy - Bladder Cancer - Product Description 18
Diagnostic Test - Neurodegenerative Diseases - Product Status 19
Diagnostic Test - Neurodegenerative Diseases - Product Description 19
EXO1000 - Product Status 20
EXO1000 - Product Description 20
ExoDx Lung(EGFR) - Product Status 21
ExoDx Lung(EGFR) - Product Description 21
ExoDx Lung(EGFR) - A Phase I/II, Open-label, Safety, Pharmacokinetic and Preliminary Efficacy Study of Oral Rociletinib in Patients with Previously Treated Mutant EGFR Non-small Cell Lung Cancer (NSCLC) 22
ExoDx Lung(T790M) - Product Status 23
ExoDx Lung(T790M) - Product Description 23
ExoDx Prostate(IntelliScore) - IVD Version - Product Status 24
ExoDx Prostate(IntelliScore) - IVD Version - Product Description 24
ExoDx Prostate(IntelliScore) - IVD Version - Clinical Evaluation of the 'ExoDx Prostate IntelliScore' in Men Presenting for Initial Biopsy; Additional Confirmation Study including Impact on Decision-making and Health Economics 25
Next-Generation Solid Tumor Mutation Panel - Product Status 26
Next-Generation Solid Tumor Mutation Panel - Product Description 26
Shahky - Product Status 27
Shahky - Product Description 27
Exosome Diagnostics Inc, Key Employees 29
Exosome Diagnostics Inc, Subsidiaries 30
Glossary 40

List of Figures
Exosome Diagnostics Inc Pipeline Products by Equipment Type 6
Exosome Diagnostics Inc Pipeline Products by Development Stage 9
Exosome Diagnostics Inc Ongoing Clinical Trials by Trial Status 11

★海外企業調査レポート[Exosome Diagnostics Inc：企業の製品パイプライン分析2018]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Cafe De Coral Holdings Limited
    Cafe De Coral Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Cafe De Coral Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Verizon Communications Inc (VZ)：企業の財務・戦略的SWOT分析
    Verizon Communications Inc (VZ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • GVK Power and Infrastructure Ltd (GVKPIL)：企業の財務・戦略的SWOT分析
    GVK Power and Infrastructure Ltd (GVKPIL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Caverion Corp：企業の戦略・SWOT・財務情報
    Caverion Corp - Strategy, SWOT and Corporate Finance Report Summary Caverion Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • aTyr Pharma Inc (LIFE)-製薬・医療分野：企業M&A・提携分析
    Summary aTyr Pharma Inc (aTyr Pharma) is a biotherapeutics company that discovers and develops physiocrine-based therapies. The company’s resolaris is a potential intravenous protein therapeutic for the treatment of rare myopathies with an immune component. It offers phyisiocrine, which is a class o …
  • Dah Chong Hong Holdings Ltd (1828)：企業の財務・戦略的SWOT分析
    Dah Chong Hong Holdings Ltd (1828) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • WSI Industries, Inc.：企業の戦略・SWOT・財務分析
    WSI Industries, Inc. - Strategy, SWOT and Corporate Finance Report Summary WSI Industries, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • SugarBud Craft Growers Corp (RRL)：企業の財務・戦略的SWOT分析
    Summary SugarBud Craft Growers Corp, (SugarBud) formerly New Range Resources Ltd is an oil and gas company that offers oil and gas exploration and development services. The company acquires, explores, operates, manages, produces, and develops crude oil and natural gas in Alberta and Saskatchewan. It …
  • Heerema International Group Services SA：企業の戦略的SWOT分析
    Heerema International Group Services SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …
  • Lidco Group Plc (LID)-医療機器分野：企業M&A・提携分析
    Summary Lidco Group Plc (LiDCO) is a medical device company that supplies hemodynamic equipment. The company offers products including LiDCOrapidv, LiDCOplus, LiDCOview and LiDCOrapid. Its LiDCOplus comprise lithium dilution, pulseCO algorithm, user display and others. LiDCO offers products to monit …
  • Ion Beam Applications SA (IBAB)：企業の財務・戦略的SWOT分析
    Ion Beam Applications SA (IBAB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Tenet Healthcare Corporation：企業の戦略・SWOT・財務分析
    Tenet Healthcare Corporation - Strategy, SWOT and Corporate Finance Report Summary Tenet Healthcare Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Legg Mason Inc：企業の戦略・SWOT・財務情報
    Legg Mason Inc - Strategy, SWOT and Corporate Finance Report Summary Legg Mason Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Coretex Products, Inc.：企業の戦略・SWOT・財務情報
    Coretex Products, Inc. - Strategy, SWOT and Corporate Finance Report Summary Coretex Products, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Safeguard Scientifics Inc (SFE)：企業の財務・戦略的SWOT分析
    Summary Safeguard Scientifics Inc (Safeguard Scientifics), formerly Lancaster Corp, is a provider of finance, healthcare and digital media solutions. The company offers business intelligence and analytics for institutional/capital markets, insurance technology, regulatory and compliance technology a …
  • Kukje Pharmaceutical Industry Co Ltd (002720)：企業の財務・戦略的SWOT分析
    Summary Kukje Pharmaceutical Industry Co Ltd (Kukje) is a manufacturer, and distributor of pharmaceuticals, cosmetics and healthcare products. The company’s products include cephalosporins, penicillins, quinolones, aminoglycosides, macrolides, other antibiotics, antifungal and antiviral agents. Kukj …
  • Astrazeneca Pharma India Ltd (ASTRAZEN)：製薬・医療：M&Aディール及び事業提携情報
    Summary AstraZeneca Pharma India Ltd (AstraZeneca), a subsidiary of AstraZeneca Plc, is a biopharmaceutical company that discovers, develops, and commercializes medicines. The company offers products in the therapeutic areas of cardiovascular and metabolic diseases, respiratory, maternal healthcare, …
  • Pioneer Corp：企業の戦略的SWOT分析
    Pioneer Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Fox Chase Cancer Center-製薬・医療分野：企業M&A・提携分析
    Summary Fox Chase Cancer Center (Fox Chase), formerly American Oncologic Hospital Inc, a subsidiary of Temple University Health System Inc, is a healthcare service provider that offers cancer care services. The center provides screening services for breast, colorectal, prostate, lung and skin cancer …
  • InKemia IUCT Group SA (IKM)：製薬・医療：M&Aディール及び事業提携情報
    Summary InKemia IUCT Group SA (InKemia IUCT), formerly Institut Univ De Ciencia i Technology SA, is a biotechnology company. The company provides research and development, technological, and consulting services. It offers customized research services. InKemia IUCT provides technology services such a …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆